Advertisement









St. Mary's pretrial supervision program earns praise as it cuts incarceration

St. Mary's County's pretrial supervision program, which is winning accolades for its results in getting criminal defendants to show up for trial and avoid new offenses without incarcerating them. The program that has been held up as a model for other Maryland jurisdictions to follow as the role of cash bail in determining who is freed diminishes.

St. Mary's pretrial supervision program earns praise as it cuts incarceration

Op-ed

We need more science in health care

Under current conditions, medical research is not science. It is deceptive. Even when results are positive they are presented in a misleading way to exaggerate their benefit. We hear that the newest cholesterol drug Repatha cuts down heart attacks by 20 percent, which sounds impressive, but in fact after two years only 15 out of 1,000 people benefit, and no lives are saved in this industry-sponsored study — numbers buried by the study's authors. The drug costs $14,000 a year. This is not

We need more science in health care


Health

UM doctors want more patients tested for gene variant that makes heart drug ineffective

Plavix is a blood thinner that prevents the blood from clotting around stents after surgery, which can reduce the risk of heart attack and stroke in people with heart disease. But the drug only works when a liver enzyme in the body activates it. About 30 percent of people have at least one gene variation that might prevent this activation and make the drug less effective.

UM doctors want more patients tested for gene variant that makes heart drug ineffective

Op-ed

Clinical trials fall short in determining drug safety

The fact that clinical trials found that opioids pose a "very small risk of developing addiction, abuse, or other serious side effects" suggests that clinical trials, as they are currently conducted, may not be able to accurately determine the safety of prescription medications.

Clinical trials fall short in determining drug safety

Health

Hopkins works to shorten time needed for drug approvals

Federal approval for a new drug can take a decade or more, but researchers at Johns Hopkins University are studying a way to shave off years for medications meant for serious outbreaks of flu, Ebola or other infectious disease

Hopkins works to shorten time needed for drug approvals











Health

Hopkins scientists develop mini-brains in promising research

Researchers at the Johns Hopkins Bloomberg School of Public Health are growing tiny replicas of the human brain to help the study of neurological diseases in a trend many hope could lead to better treatments and even cures for some of the most debilitating illnesses.

Hopkins scientists develop mini-brains in promising research


Health

Vaccine for common respiratory infection shows promise in trials

Nearly all children will catch the common wintertime respiratory infection known as RSV before they are two, but for decades researchers have been unable to develop an means to prevent it. Now a vaccine is showing promise in early trials at Johns Hopkins University.

Vaccine for common respiratory infection shows promise in trials


Health

Industry funds six times more clinical trials than feds, research shows

The drug and device industry now funds six times more clinical trials than the federal government, according to Johns Hopkins University researchers. That means companies with financial interests in the studies now have more control over what doctors and patients learn about new treatments.

Industry funds six times more clinical trials than feds, research shows

Health

HIV vaccine to be tested on people

Decades-long research on a promising HIV/AIDS vaccine at the University of Maryland School of Medicine is moving into the critical human testing stage.

HIV vaccine to be tested on people








Health

Hospitals receive funding from drug and device makers

Maryland's hospitals and doctors took in more than $7.6 million in payments for research, speeches and other work from drug and device manufacturers in 2014, according to federal authorities who have been releasing payment data periodically.

Hospitals receive funding from drug and device makers


Harford County

Aberdeen Proving Ground research to help end Ebola virus

The U.S. Army Edgewood Chemical Biological Center and the U.S. Army Medical Research Institute of Infectious Diseases are partnering to help expedite progress in the global fight against Ebola. ECBC is working with USAMRIID on two critical studies –a vaccine study and a biomarker study – that will advance the global fight against Ebola.
Aberdeen Proving Ground research to help end Ebola virus

Health

Baltimore's Profectus marks key step in race for Ebola vaccine

Research being published Thursday suggests that an Ebola vaccine being developed by Baltimore company Profectus BioSciences is effective against the strain of the virus that has ravaged West Africa, a milestone the company says is a first in the race to prevent future Ebola outbreaks.

Baltimore's Profectus marks key step in race for Ebola vaccine



Op-ed

Look to animals to cure Ebola

To beat Ebola as we've overcome other global epidemics, officials must preserve access to animal research. Cures for this deadly pathogen — and thousands of lives — depend on it.

Look to animals to cure Ebola

Health

Thousands to receive experimental Ebola vaccines in West Africa

Thousands of people are to be injected with two experimental Ebola vaccines in trials in West Africa within a couple of weeks, and a Baltimore biotechnology company is launching a human trial of its own candidate in June, as scientists and public health officials work to end the deadly epidemic.

Thousands to receive experimental Ebola vaccines in West Africa






Advertisement